(NASDAQ: RXST) Rxsight's forecast annual revenue growth rate of 9.11% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.86%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.4%.
Rxsight's revenue in 2026 is $127,478,000.On average, 11 Wall Street analysts forecast RXST's revenue for 2026 to be $5,747,505,194, with the lowest RXST revenue forecast at $5,176,645,955, and the highest RXST revenue forecast at $6,514,998,324. On average, 11 Wall Street analysts forecast RXST's revenue for 2027 to be $6,178,443,893, with the lowest RXST revenue forecast at $5,545,903,708, and the highest RXST revenue forecast at $7,165,753,018.
In 2028, RXST is forecast to generate $6,949,248,753 in revenue, with the lowest revenue forecast at $5,841,889,462 and the highest revenue forecast at $8,871,707,275.